Objective:Stromal interaction molecule 1 (STIM 1) overexpression has been reported to play an important role in progression of several cancers.However,the mechanism of STIM1 overexpression and its relationship with hypoxia in pancreatic ductal adenocarcinoma (PDAC) remains unclear.Methods:STIM1 and HIF-1αexpression was tested using immunohistochemistry in tissue microarray (TMA) including pancreatic cancer and matched normal pancreatic tissues,and their relationships with clinicopathological parameters were statistically analyzed.q-PCR,West blot,ChIP,and luciferase assay were employed to 030 analyze transcriptional regulation between HIF-1α and STIM 1 in pancreatic cancer PANC-1 cells.Results:Both STIM1 and HIF-1α showed higher positive rates and up-regulated expression in cancer tissues compared to that of normal tissues (P ＜ 0.05).The Kaplan-Meier method revealed that higher HIF-1α and STIM1 expression levels were significantly correlated with decreased disease-free survival (P =0.025 and P =0.029,respectively).The expression of HIF-1α showed a significant positive correlation with that of STIM1 in cancer tissues (rs =0.3343,P =0.0011) and pancreatic cancer cell lines.Furthermore,ChIP and luciferase assays confirmed that HIF-1α bound to the STIM1 promoter and regulated its expression in PANC-1 cells.Conclusions:In hypoxia microenvironment,up-regulated expression of STIM1 mediated by HIF-1αpromotes PDAC progression.HIF-1α and STIM1 are potential prognostic markers and/or therapeutic targets for PDAC treatment.